All letters are subject to editing and may be shortened. General letters can be sent to bjgpdisc@rcgp.org.uk (please include your postal address for publication), and letters responding directly to BJGP articles can be submitted online via eLetters. We regret we cannot notify authors regarding publication.
For submission instructions visit: bjgp.org/letters
In Tso et al ’s article, it is stated that females on adalimumab should not breastfeed until at least 5 months after the last treatment, according to the manufacturer’s …